NOVOPHARM RANITIDINE FORM 1 CONTAINS DETECTABLE AMOUNTS FORM 2, GLAXO CONTENDS AT TRIAL; CLAIMS NOVOPHARM STOLE MANUFACTURING TRADE SECRETS

Novopharm's generic version of Glaxo Wellcome's Zantac contains detectable amounts of Form 2 ranitidine hydrochloride, Glaxo contended in opening statements April 16 in Elizabeth City, N.C. federal court in a suit Glaxo filed against Novopharm for its filing of an ANDA for Form 1 ranitidine.